新西兰关节置换外科医生对术者水平结局报告的调查
该调查以五点李克特量表问卷评估新西兰髋膝关节置换外科医生对术者水平结局监测的看法,151名医生完成调查,回复率50%。受访者认同监测关节置换结局重要且翻修率是可接受的绩效指标,支持风险校正翻修率、更近时间窗及纳入患者报告结局,但不支持公开报告术者或医院水平结局。
要点
- 受访者认同监测关节置换结局重要,翻修率是可接受的绩效衡量指标。
- 支持报告风险校正翻修率、更近时间窗及纳入患者报告结局监测绩效。
- 不支持公开报告术者水平或医院水平结局。
核心结论
- 调查结果支持使用翻修率保密监测术者水平关节置换结局,并提示同时使用患者报告结局测量工具是可接受的。
研究设计与样本
- 该调查由9个关于术者特异性结局报告的问题(采用五点李克特量表)和5个人口学问题组成,发放给所有现任髋膝关节置换外科医生,共151名完成,回复率50%。
主要发现
- 受访者认同监测关节置换结局重要,且翻修率是可接受的绩效衡量指标。
- 受访者支持报告风险校正翻修率、更近的时间窗,以及监测绩效时纳入患者报告结局。
- 外科医生不支持公开报告术者水平或医院水平结局。
临床怎么用
- 原文结论支持使用翻修率保密监测术者水平关节置换结局,并提示同时使用患者报告结局测量工具是可接受的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgeon-specific outcome monitoring has become increasingly prevalent over the last 3 decades. The New Zealand Orthopaedic Association monitors individual surgeon performance through 2 mechanisms: arthroplasty revision rates derived from the New Zealand Joint Registry and a practice visit program. Despite remaining confidential, surgeon-level outcome reporting remains contentious. The purpose of this survey was to evaluate the opinions of hip and knee arthroplasty surgeons in New Zealand on the perceived importance of outcome monitoring, current methods used to evaluate surgeon-specific outcomes, and potential improvements identified through literature review and discussion with other registries. METHODS: The survey consisted of 9 questions on surgeon-specific outcome reporting, using a five-point Likert scale, and 5 demographic questions. It was distributed to all current hip and knee arthroplasty surgeons. There were 151 hip and knee arthroplasty surgeons who completed the survey, a response rate of 50%. RESULTS: Respondents agreed that monitoring arthroplasty outcomes is important and that revision rates are an acceptable measure of performance. Reporting risk-adjusted revision rates and more recent timeframes were supported, as was including patient-reported outcomes when monitoring performance. Surgeons did not support public reporting of surgeon-level or hospital-level outcomes. CONCLUSION: The findings of this survey support the use of revision rates to confidentially monitor surgeon-level arthroplasty outcomes and suggest that concurrent use of patient-reported outcome measures would be acceptable.
引用
- Lingard MCH, Willis J, Frampton CMA, et al. Survey of New Zealand Arthroplasty Surgeons on Surgeon-Level Outcome Reporting. J Arthroplasty. 2023. PMID: 37279844. doi:10.1016/j.arth.2023.05.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。